(NP (NP (NN Regulation)) (PP (IN of) (NP (DT the) (JJ Ets-related) (NN transcription) (NN factor) (NN Elf-1))) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VBG binding) (PP (TO to) (NP (DT the) (NN retinoblastoma) (NN protein)))))) (. .))
(S (NP-SBJ (NP (DT The) (NN retinoblastoma) (NN gene) (NN product)) (PRN (-LRB- -LRB-) (NP (NN Rb)) (-RRB- -RRB-))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ nuclear) (NN phosphoprotein)) (SBAR (WHNP-20 (WDT that)) (S (NP-SBJ (-NONE- *T*-20)) (VP (VBZ regulates) (NP (NN cell) (NN cycle) (NN progression))))))) (. .))
(S (NP-SBJ (NN Elf-1)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ lymphoid-specific) (NN Ets) (NN transcription) (NN factor)) (SBAR (WHNP-21 (WDT that)) (S (NP-SBJ (-NONE- *T*-21)) (VP (VBZ regulates) (NP (JJ inducible) (NN gene) (NN expression)) (PP-TMP (IN during) (NP (NN T) (NN cell) (NN activation)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP-SBJ (PRP it)) (VP (VBZ is) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ (NN Elf-1)) (VP (VBZ contains) (NP (NP (DT a) (NN sequence) (NN motif)) (SBAR (WHNP-22 (WDT that)) (S (NP-SBJ (-NONE- *T*-22)) (VP-COOD (VP (VBZ is) (ADJP-PRD (RB highly) (JJ related) (PP (TO to) (NP (NP (DT the) (NN Rb) (NN binding) (NNS sites)) (PP (IN of) (NP (JJ several) (JJ viral) (NNS oncoproteins))))))) (CC and) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (NN pocket) (NN region)) (PP (IN of) (NP (NN Rb))))) (ADVP-COOD (CC both) (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo))))))))))))) (. .))
(S (NP-SBJ-24 (NN Elf-1)) (VP-COOD (VP (VBZ binds) (ADVP (RB exclusively)) (PP (TO to) (NP (NP (DT the) (JJ underphosphorylated) (NN form)) (PP (IN of) (NP (NN Rb)))))) (CC and) (VP (VBZ fails) (S (NP-SBJ (-NONE- *-24)) (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NP (NN Rb) (NNS mutants)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN retinoblastoma))))))))))))) (. .))
(S (NP-SBJ (NN Co-immunoprecipitation) (NNS experiments)) (VP (VBD demonstrated) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP-COOD (NP (NN Elf-1)) (CC and) (NP (NN Rb))) (PP (IN in) (NP (VBG resting) (JJ normal) (JJ human) (NN T) (NNS cells))))))) (. .))
(S (PP-TMP (IN After) (NP (NN T) (NN cell) (NN activation))) (, ,) (NP-SBJ (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NN Rb)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NN Elf-1))) (, ,) (SBAR (WHNP-25 (WDT which)) (S (NP-SBJ-26 (-NONE- *T*-25)) (VP (VBZ is) (VP (VBN correlated) (NP (-NONE- *-26)) (ADVP-TMP (RB temporally)) (PP (IN with) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ Elf-1-mediated) (NN transcription)))))))))))) (. .))
(S (NP-SBJ (NP (NN Overexpression)) (PP (IN of) (NP (NP (DT a) (JJ phosphorylation-defective) (NN form)) (PP (IN of) (NP (NN Rb)))))) (VP (VBD inhibited) (NP (JJ Elf-1-dependent) (NN transcription)) (PP-TMP (IN during) (NP (NN T) (NN cell) (NN activation)))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NN Rb)) (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (DT a) (JJ lineage-restricted) (NN Ets) (NN transcription) (NN factor))))))) (. .))
(S (NP-SBJ (DT This) (JJ regulated) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ important)) (PP (IN for) (NP (NP (DT the) (NN coordination)) (PP (IN of) (NP (NP (JJ lineage-specific) (NN effector) (NNS functions)) (PP (JJ such) (IN as) (NP (NN lymphokine) (NN production))))) (PP (IN with) (NP (NP (NN cell) (NN cycle) (NN progression)) (PP (IN in) (NP (VBN activated) (NN T) (NNS cells))))))))) (. .))
